Advertisement
UK markets open in 5 hours 26 minutes
  • NIKKEI 225

    37,924.31
    -535.77 (-1.39%)
     
  • HANG SENG

    17,201.27
    0.00 (0.00%)
     
  • CRUDE OIL

    82.72
    -0.09 (-0.11%)
     
  • GOLD FUTURES

    2,330.50
    -7.90 (-0.34%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,750.92
    -1,798.98 (-3.36%)
     
  • CMC Crypto 200

    1,393.47
    -30.63 (-2.15%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Is This Vaccine Stock a Buy?

Is This Vaccine Stock a Buy?

The recent surge in COVID-19 cases caused by the new and more contagious omicron variant of the coronavirus has taught us at least one thing: There's still a dire need for effective vaccines against this potentially deadly disease. Several companies are still looking to enter the coronavirus vaccine market, even though Pfizer and Moderna currently dominate it. One biotech that is slowly advancing a coronavirus vaccine candidate is Vaxart (NASDAQ: VXRT).